A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy

Clinical trial NCT05979311 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05979311
Sponsor: ViiV Healthcare
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HIV HIV Infections

Start date: 2024-02-21
Primary completion: 2026-04-15
Enrollment: 307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.